STAREE-Mind Imaging Study: a randomised placebo-controlled trial of atorvastatin for prevention of cerebrovascular decline and neurodegeneration in older individuals
Introduction Cerebrovascular disease and neurodegeneration are causes of cognitive decline and dementia, for which primary prevention options are currently lacking. Statins are well-tolerated and widely available medications that potentially have neuroprotective effects. The STAREE-Mind Imaging Stud...
Saved in:
| Main Authors: | Sharon L Naismith, Craig S Anderson, Stephane Heritier, Michael O'Sullivan, Sophia Zoungas, Joanne Ryan, Ian H Harding, Simone Spark, Meng Law, Trevor T-J Chong, Zachary Flanagan, Richard McIntyre, Gary Egan |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-10-01
|
| Series: | BMJ Neurology Open |
| Online Access: | https://neurologyopen.bmj.com/content/5/2/e000541.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cerebrovascular burden and neurodegeneration linked to 15-year odor identification decline in older adults
by: Javier Oltra, et al.
Published: (2025-03-01) -
Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial)
by: Rory Wolfe, et al.
Published: (2023-04-01) -
Corrigendum: Cerebrovascular burden and neurodegeneration linked to 15-year odor identification decline in older adults
by: Javier Oltra, et al.
Published: (2025-04-01) -
Staring secondaries, where is the primary?
by: Sundaram P, et al.
Published: (2010-12-01) -
Stare teksty w nowych szatach
by: Alina Madej
Published: (2003-06-01)